• 1. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 2. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 3. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzenesulfonamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides Aminobenzenesulfonamides

Sulfadiazine-13C6: A Stable Isotope Labeled Compound for Advanced Research Applications

Sulfadiazine-13C6 (CAS No. 1189426-16-1) is a stable isotope-labeled derivative of sulfadiazine, a well-known sulfonamide antibiotic. This compound is increasingly utilized in various research applications, particularly in the fields of medicinal chemistry, pharmacology, and bioanalytical chemistry. The incorporation of 13C6 isotopes into the molecular structure of sulfadiazine provides researchers with a powerful tool for studying the metabolism, pharmacokinetics, and bioavailability of this important antibiotic.

The chemical structure of Sulfadiazine-13C6 is identical to that of its unlabeled counterpart, with the exception of the six carbon atoms being replaced by their stable isotope 13C. This substitution does not alter the chemical properties or biological activity of the molecule but allows for precise tracking and quantification using advanced analytical techniques such as mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy.

In recent years, the use of stable isotope-labeled compounds like Sulfadiazine-13C6 has gained significant traction in pharmaceutical research. A study published in the Journal of Pharmaceutical and Biomedical Analysis highlighted the utility of Sulfadiazine-13C6 in developing robust methods for the quantification of sulfadiazine in biological matrices. The researchers demonstrated that the labeled compound provided enhanced sensitivity and accuracy compared to traditional methods, making it an invaluable tool for pharmacokinetic studies.

Another area where Sulfadiazine-13C6 has shown promise is in the investigation of drug-drug interactions. A study conducted by a team at the University of California, San Francisco, used Sulfadiazine-13C6 to explore the metabolic pathways and potential interactions between sulfadiazine and other commonly prescribed medications. The results indicated that the labeled compound facilitated a more detailed understanding of these interactions, which is crucial for optimizing therapeutic regimens and minimizing adverse effects.

The stability and reliability of Sulfadiazine-13C6 also make it an ideal candidate for use in clinical trials. Researchers at the National Institutes of Health (NIH) have utilized this compound to monitor drug concentrations in patients undergoing treatment for bacterial infections. The ability to accurately measure drug levels in real-time has significant implications for personalized medicine, allowing clinicians to tailor dosing regimens based on individual patient responses.

Beyond its applications in pharmaceutical research, Sulfadiazine-13C6 has also found use in environmental studies. Scientists at the Environmental Protection Agency (EPA) have employed this labeled compound to trace the fate and transport of sulfadiazine in aquatic ecosystems. By using Sulfadiazine-13C6, researchers can better understand how this antibiotic persists in the environment and its potential impact on non-target organisms.

In conclusion, Sulfadiazine-13C6 (CAS No. 1189426-16-1) represents a significant advancement in the field of stable isotope-labeled compounds. Its unique properties make it an essential tool for researchers across multiple disciplines, from pharmaceutical development to environmental monitoring. As ongoing research continues to uncover new applications and insights, the importance of compounds like Sulfadiazine-13C6 will only continue to grow.

• 17103-46-7(4-amino-N-(1H-imidazol-2-yl)Benzenesulfonamide,)
• 599-88-2(4-Amino-N-(5-methylpyrimidin-2-yl)benzenesulfonamide)
• 64047-46-7(Benzenesulfonamide,4-isothiocyanato-N-2-pyrimidinyl-)
• 3271-01-0(Benzenesulfonamide,4-amino-N-(5-ethyl-2-pyrimidinyl)-)
• 5414-66-4(Benzenesulfonamide,4-amino-N-(5-bromo-2-pyrimidinyl)-)
• 16699-12-0(2-Benzenesulfonamidopyrimidine)
• 68-35-9(Sulfadiazine)
• 22199-08-2(Silver sulfadiazine)
• 547-32-0(Sulfadiazine sodium)
• 61567-34-8(Silver(1+), (4-amino-N-2-pyrimidinylbenzenesulfonamide)-, nitrate)